Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Rye, IH"'
Autor:
Glodzik, D, Morganella, S, Davies, H, Simpson, PT, Li, Y, Zou, X, Diez-Perez, J, Staaf, J, Alexandrov, LB, Smid, M, Brinkman, AB, Rye, IH, Russnes, H, Raine, K, Purdie, CA, Lakhani, Thompson, AM, Birney, E, Stunnenberg, HG, Van De Vijver, MJ, Martens, JWM, Børresen-Dale, A-L, Richardson, AL, Kong, G, Viari, A, Easton, D, Evan, G, Campbell, PJ, Stratton, MR, Nik-Zainal, S
Somatic rearrangements contribute to the mutagenized landscape of cancer genomes. Here, we systematically interrogated rearrangements in 560 breast cancers by using a piecewise constant fitting approach. We identified 33 hotspots of large (>100 kb) t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4731ff889d86b21a8f6e1d7ef053f85
Autor:
Otterlei Fjørtoft M; Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Radium Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Huse K; Department of Cancer Immunology, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Radium Hospital, Oslo, Norway., Rye IH; Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Radium Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. ingrye@rr-research.no.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 May 23; Vol. 63, pp. 359-367. Date of Electronic Publication: 2024 May 23.
Autor:
Rye IH; Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Radiumhospitalet, Oslo, Norway., Huse K; Department of Cancer Immunology, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital Radiumhospitalet, Norway.; KG Jebsen Centre for B-Cell Malignancies, Institute for Clinical Medicine, University of Oslo, Norway., Josefsson SE; Department of Cancer Immunology, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital Radiumhospitalet, Norway.; KG Jebsen Centre for B-Cell Malignancies, Institute for Clinical Medicine, University of Oslo, Norway., Kildal W; Division of Cancer Medicine, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Radiumhospitalet, Oslo, Norway., Danielsen HE; Division of Cancer Medicine, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.; Department of Informatics, University of Oslo, Norway.; Nuffield Division of Clinical Laboratory Sciences, University of Oxford, UK., Schlichting E; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway., Garred Ø; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Norway., Riis ML; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway., Osbreac; Oslo Breast Cancer Consortium, Oslo University Hospital, Norway., Lingjaerde OC; Institute for Bioinformatics, University of Oslo, Norway., Myklebust JH; Department of Cancer Immunology, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital Radiumhospitalet, Norway.; KG Jebsen Centre for B-Cell Malignancies, Institute for Clinical Medicine, University of Oslo, Norway., Russnes HG; Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Norway.
Publikováno v:
Molecular oncology [Mol Oncol] 2022 Jan; Vol. 16 (1), pp. 88-103. Date of Electronic Publication: 2021 Jul 12.
Autor:
Janiszewska M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida, USA., Stein S; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Metzger Filho O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Eng J; OHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Kingston NL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Harper NW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Rye IH; Department of Pathology, Division of Laboratory Medicine, and Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Alečković M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Trinh A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Murphy KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Marangoni E; Department of Translational Research, Institut Curie, Paris, France., Cristea S; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA., Oakes B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Krop IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Russnes HG; Department of Pathology, Division of Laboratory Medicine, and Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Spellman PT; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.; Department of Molecular and Medical Genetics, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA., Bucher E; OHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Hu Z; OHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Chin K; OHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Gray JW; OHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Michor F; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Ludwig Center at Harvard Medical School, Boston, Massachusetts, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Ludwig Center at Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
JCI insight [JCI Insight] 2021 Jun 08; Vol. 6 (11). Date of Electronic Publication: 2021 Jun 08.
Autor:
Taylor-King JP; Mathematical Institute, University of Oxford, Oxford, UK.; Department of Integrated Mathematical Oncology, Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Institute of Molecular Systems Biology, Department of Biology, ETHZ, Zurich, Switzerland., Baratchart E; Department of Integrated Mathematical Oncology, Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Dhawan A; Department of Oncology, University of Oxford, Oxford, UK., Coker EA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK., Rye IH; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway., Russnes H; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway., Chapman SJ; Mathematical Institute, University of Oxford, Oxford, UK., Basanta D; Department of Integrated Mathematical Oncology, Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Marusyk A; Department of Cancer Imaging and Metabolism, Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Publikováno v:
Mathematical medicine and biology : a journal of the IMA [Math Med Biol] 2019 Mar 14; Vol. 36 (1), pp. 93-112.
Autor:
Głodzik D; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Wellcome Trust Sanger Institute, Hinxton, Cambridge., Purdie C; Department of Pathology, Ninewells Hospital & Medical School, Dundee, UK., Rye IH; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Simpson PT; Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia., Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Span PN; Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Russnes HG; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Department of Pathology, Oslo University Hospital, Oslo, Norway., Nik-Zainal S; Wellcome Trust Sanger Institute, Hinxton, Cambridge; Academic Department of Medical Genetics, The Clinical School University of Cambridge, Cambridge, UK. Electronic address: sn206@cam.ac.uk.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Nov 01; Vol. 29 (11), pp. 2223-2231.
Autor:
Rye IH; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Norway., Trinh A; Cancer Research UK, Cambridge Institute, University of Cambridge, UK., Saetersdal AB; Department of Oncology, Oslo University Hospital, Norway., Nebdal D; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Norway., Lingjaerde OC; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Norway.; Biomedical Informatics Division, Department of Computer Science, University of Oslo, Norway., Almendro V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Norway.; Department of Clinical Medicine, University of Oslo, Norway., Helland Å; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Norway.; Department of Oncology, Oslo University Hospital, Norway.; Department of Clinical Medicine, University of Oslo, Norway., Markowetz F; Cancer Research UK, Cambridge Institute, University of Cambridge, UK., Russnes HG; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Norway.; Department of Pathology, Oslo University Hospital, Norway.
Publikováno v:
Molecular oncology [Mol Oncol] 2018 Nov; Vol. 12 (11), pp. 1838-1855. Date of Electronic Publication: 2018 Sep 21.
Autor:
Glodzik D, Morganella S, Davies H, Simpson PT, Li Y, Zou X, Diez-Perez J, Staaf J, Alexandrov LB, Smid M, Brinkman AB, Rye IH, Russnes H, Raine K, Purdie CA, Lakhani SR, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JWM, Børresen-Dale AL, Richardson AL, Kong G, Viari A, Easton D, Evan G, Campbell PJ, Stratton MR, Nik-Zainal S
Publikováno v:
Nature genetics [Nat Genet] 2017 Oct 27; Vol. 49 (11), pp. 1661.
Autor:
Glodzik D; Wellcome Trust Sanger Institute, Cambridge, UK., Morganella S; Wellcome Trust Sanger Institute, Cambridge, UK., Davies H; Wellcome Trust Sanger Institute, Cambridge, UK., Simpson PT; The University of Queensland: UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland, Australia., Li Y; Wellcome Trust Sanger Institute, Cambridge, UK., Zou X; Wellcome Trust Sanger Institute, Cambridge, UK., Diez-Perez J; Wellcome Trust Sanger Institute, Cambridge, UK., Staaf J; Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden., Alexandrov LB; Wellcome Trust Sanger Institute, Cambridge, UK.; Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, New Mexico, USA.; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico, USA., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, the Netherlands., Brinkman AB; Department of Molecular Biology, Faculties of Science and Medicine, Radboud University, Nijmegen, the Netherlands., Rye IH; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norwegian Radiumhospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Russnes H; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norwegian Radiumhospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Raine K; Wellcome Trust Sanger Institute, Cambridge, UK., Purdie CA; Department of Pathology, Ninewells Hospital &Medical School, Dundee, UK., Lakhani SR; The University of Queensland: UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland, Australia.; Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Thompson AM; Department of Pathology, Ninewells Hospital &Medical School, Dundee, UK.; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Birney E; European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridgeshire, UK., Stunnenberg HG; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, the Netherlands., van de Vijver MJ; Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, the Netherlands., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norwegian Radiumhospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Richardson AL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kong G; Department of Pathology, College of Medicine, Hanyang University, Seoul, South Korea., Viari A; Equipe Erable, INRIA Grenoble-Rhône-Alpes, Montbonnot-Saint Martin, France.; Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France., Easton D; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Evan G; Department of Biochemistry, University of Cambridge, Cambridge, UK., Campbell PJ; Wellcome Trust Sanger Institute, Cambridge, UK., Stratton MR; Wellcome Trust Sanger Institute, Cambridge, UK., Nik-Zainal S; Wellcome Trust Sanger Institute, Cambridge, UK.; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Publikováno v:
Nature genetics [Nat Genet] 2017 Mar; Vol. 49 (3), pp. 341-348. Date of Electronic Publication: 2017 Jan 23.
Autor:
Rye IH; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, 0424, Oslo, 0310, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Lundin P, Månér S, Fjelldal R, Naume B, Wigler M, Hicks J, Børresen-Dale AL, Zetterberg A, Russnes HG
Publikováno v:
Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2015 Apr; Vol. 54 (4), pp. 235-48. Date of Electronic Publication: 2014 Dec 26.